Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents	Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder	Active, not recruiting	Phase 2	2026-01-20		NCT05347771

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Childhood Asthma in Urban Settings (CAUSE)	1
National Institute of Allergy and Infectious Diseases (NIAID)	402
Regeneron Pharmaceuticals	238
Rho Federal Systems Division, Inc.	12

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ann & Robert H. Lurie Children's Hospital of Chicago: Division of Allergy and Immunology	Chicago	United States	3
Boston Children's Hospital: Department of Immunology	Boston	United States	3
Children's Hospital Colorado: Allergy Program	Aurora	United States	3
Children's National Medical Center: Children's Research Institute	Washington D.C.	United States	3
Cincinnati Children's Hospital Medical Center: Asthma Center	Cincinnati	United States	4
Columbia University Medical Center: Division of Pediatric Pulmonology	New York	United States	2
Icahn School of Medicine at Mount Sinai: Division of Clinical Immunology, Immunology Institute	New York	United States	3
Washington University at St. Louis	St Louis	United States	2